News | August 09, 2010

Invatec's Purchase May Bolster U.S. Balloon Market Share

August 9, 2010 – According to Millennium Research Group (MRG), a medical technology market research company, Invatec has traditionally held a much stronger position in the European percutaneous transluminal angioplasty (PTA) balloon catheter market compared to the United States. Nonetheless, sales of Invatec's PTA balloon catheters picked up in the United States in the first quarter of 2010, according to MRG's Peripheral Vascular Marketrack study, coinciding with Medtronic's announcement it would purchase the company. Further success of the Invatec product lines in the United States will be bolstered by Medtronic's established sales and marketing efforts.

Invatec, whose purchase by Medtronic was finalized in April, is known for its high-quality PTA product line for the treatment of peripheral artery disease, especially in Europe, where the company was the fourth-leading competitor in the PTA balloon catheter market in 2009.

Conversely, Invatec products captured approximately 5 percent of the U.S. PTA balloon catheter market in 2009, where it offered only a selection of its products. Medtronic's acquisition of Invatec is expected to benefit both companies and has the potential for a synergistic relationship -- with Medtronic broadening its peripheral vascular product line and Invatec expanding its presence in the US market.

"Invatec has traditionally maintained only a small presence in the U.S. PTA balloon catheter market, meaning significant opportunity exists for Medtronic to expand the presence of these product lines in the U.S.," said Stephanie Labelle, manager of the cardiovascular division at MRG.
"The Invatec product line will benefit from Medtronic's existing relationships with physicians using its drug-eluting coronary stents and aortic stent grafts, therefore expanding Invatec's penetration into U.S. facilities. In addition, Medtronic may consider bringing additional Invatec products to the U.S. marketplace that would further increase the company's share of the peripheral vascular device market, including the In.Pact Admiral drug-eluting balloon, the Cristallo Ideale carotid stent, and the innovative Mo.Ma Ultra embolic protection device, which are currently available in Europe, and would further increase the company's competitiveness in the U.S. peripheral vascular device market."

MRG's Peripheral Vascular Marketrack project gathers facility level procedure and product usage data on treatments for peripheral artery disease. Data is collected on a monthly basis in the United States and a quarterly basis in Europe from interventional radiology labs, interventional cardiology labs, and operating rooms throughout the United States and Europe. Marketrack subscribers receive thousands of data points, including usage (units, average selling price, and revenue), procedure, competitor, and brand information.

For more information:

Related Content

Gore Molding & Occlusion Balloon for Endovascular Aortic Repair Receives FDA Approval
Technology | Balloon Catheter | August 23, 2018
W. L. Gore & Associates Inc. (Gore) announced U.S. Food and Drug Administration (FDA) 510(k) clearance for the Gore...
Cardiovascular Systems Inc. and OrbusNeich Announce FDA Clearance  of Sapphire II Pro 1mm Coronary Balloon
Technology | Balloon Catheter | March 21, 2018
Cardiovascular Systems Inc. (CSI) recently announced that the U.S. Food and Drug Administration (FDA) has granted 510(k...
Cardiovascular Systems Expands Product Portfolio for Peripheral and Coronary Interventions
News | Balloon Catheter | January 24, 2018
Cardiovascular Systems Inc. recently announced two new partnerships broadening the company’s product portfolio. CSI is...
Abbott recalls its NC Balloon catheters
News | Balloon Catheter | May 22, 2017
May 22, 2017 — Abbott Vascular has initiated a voluntary recall of specific lots of three catheters due to 19 reports
Videos | Balloon Catheter | November 16, 2016
A discussion with Todd Brinton, M.D., about the newly FDA-cleared Shockwave Medical Lithoplasty System, at the Transc
NuCryo Vascular, Next Generation Cryoplasty Inflation Device, PolarCath Balloon Dilatation System

PolarCath Balloon Dilatation System image courtesy of NuCryo Vascular

Technology | Balloon Catheter | March 28, 2016
NuCryo Vascular LLC announced the launch of the Next Generation Cryoplasty Inflation device. The device received U.S....
NuCryo Vascular, FDA clearance, next-gen, PolarCath System, cryoplasty inflation device
Technology | Balloon Catheter | January 12, 2016
NuCryo Vascular LLC announced that they have received U.S. Food and Drug Administration (FDA) 510(k) clearance on the...
Videos | Balloon Catheter | October 30, 2015
Todd Brinton, M.D., clinical associate professor and consulting associate professor of bioengineering at Stanford Uni
Overlay Init